Literature DB >> 12568712

Chromosome-based vectors for gene therapy.

H J Lipps1, A C W Jenke, K Nehlsen, M F Scinteie, I M Stehle, J Bode.   

Abstract

Currently used vectors in human gene therapy suffer from a number of limitations with respect to safety and reproducibility. There is increasing agreement that the ideal vector for gene therapy should be completely based on chromosomal elements and behave as an independent functional unit after integration into the genome or when retained as an episome. In this review we will first discuss the chromosomal elements, such as enhancers, locus control regions, boundary elements, insulators and scaffold- or matrix-attachment regions, involved in the hierarchic regulation of mammalian gene expression and replication. These elements have been used to design vectors that behave as artificial domains when integrating into the genome. We then discuss recent progress in the use of mammalian artificial chromosomes and small circular non-viral vectors for their use as expression systems in mammalian cells.

Entities:  

Mesh:

Year:  2003        PMID: 12568712     DOI: 10.1016/s0378-1119(02)01215-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  20 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  The c-myc insulator element and matrix attachment regions define the c-myc chromosomal domain.

Authors:  Wendy M Gombert; Stephen D Farris; Eric D Rubio; Kristin M Morey-Rosler; William H Schubach; Anton Krumm
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  An episomal mammalian replicon: sequence-independent binding of the origin recognition complex.

Authors:  Daniel Schaarschmidt; Jens Baltin; Isa M Stehle; Hans J Lipps; Rolf Knippers
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

Review 4.  Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems.

Authors:  Sabine Boeckle; Ernst Wagner
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

5.  Interspecific transfer of mammalian artificial chromosomes between farm animals.

Authors:  Filomena Monica Cavaliere; Gian Luca Scoarughi; Carmen Cimmino
Journal:  Chromosome Res       Date:  2009-07-23       Impact factor: 5.239

6.  Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation.

Authors:  Chun Chu; Yun Zhang; Ruben J Boado; William M Pardridge
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

7.  Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation.

Authors:  Andreas C W Jenke; Monica F Scinteie; Isa M Stehle; Hans J Lipps
Journal:  Mol Biol Rep       Date:  2004-06       Impact factor: 2.316

8.  Stable S/MAR-based episomal vectors are regulated at the chromatin level.

Authors:  Federico Tessadori; Kang Zeng; Erik Manders; Martijn Riool; Dean Jackson; Roel van Driel
Journal:  Chromosome Res       Date:  2010-11-16       Impact factor: 5.239

Review 9.  Gene transfer to the outflow tract.

Authors:  Yalong Dang; Ralitsa Loewen; Hardik A Parikh; Pritha Roy; Nils A Loewen
Journal:  Exp Eye Res       Date:  2016-04-27       Impact factor: 3.467

10.  Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1.

Authors:  Andreas C W Jenke; Andreas D Wilhelm; Valerie Orth; Hans Joachim Lipps; Ulrike Protzer; Stefan Wirth
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.